Group One Trading
ANRO icon

Group One Trading’s Alto Neuroscience ANRO Stock Holding History

Group One Trading’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-400
Closed -$9.25K – 8654
2026
Q1 		$8.99K Sell
400
-1,013
-72% -$18.8K ﹤0.01% 6425
2025
Q4 		$25.2K Sell
1,413
-1,245
-47% -$15.7K ﹤0.01% 6182
2025
Q3 		$10.7K Buy
2,658
+1,833
+222% +$6.08K ﹤0.01% 7124
2025
Q2 		$1.81K Buy
825
+334
+68% +$795 ﹤0.01% 7436
2025
Q1 		$1.06K Buy
+491
New +$1.76K ﹤0.01% 7160

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Group One Trading's ANRO Position: Q2 2026 in Review

Group One Trading sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 400 shares — an estimated $9.25K sold.

Group One Trading first reported a position in ANRO in Q1 2025 and held it in 5 quarters. The position peaked at $25.2K in Q4 2025. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Group One Trading reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 400 Alto Neuroscience shares in Q2 2026, an estimated $9.25K.
  • Group One Trading first reported a position in Alto Neuroscience in Q1 2025 and held it in 5 quarters.
  • Group One Trading's Alto Neuroscience position peaked at $25.2K in Q4 2025.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.